Clinical Study

Venous Thromboembolism Following Colorectal Surgery for Suspected or Confirmed Malignancy

Table 1

Pharmacological VTE prophylaxis dose regimes.

Pharmacological prophylaxis dose regime% of patients% of patients post discharge prophylaxis12 month VTE incidence (%)Major bleeding complications (%)

LMWH 20 mg daily5.30.700
LMWH 40 mg daily30161.20.7
LDUH 5000 IU twice daily30.74.711.3
LDUH 5000 IU three times daily3.30.700
LDUH followed by LMWH10.74.70.20.7
None or inadequate LDUH20400.7